Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662579-24-000086
Filing Date
2024-09-20
Accepted
2024-09-20 16:13:50
Documents
1
Period of Report
2024-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1726863223.html 4  
1 FORM 4 wk-form4_1726863223.xml 4 3350
  Complete submission text file 0001662579-24-000086.txt   4836
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 120 WATERTOWN MA 02472
Business Address
Adams Kendra (Reporting) CIK: 0001991929 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 241313523